Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 4 Open-market buy Chief Financial Officer bought 30,800 shares at $5.12 ($157,696)
  2. 4 Open-market buy Chief Financial Officer bought 17,900 shares at $3.92 ($70,168)
  3. 4 Open-market buy Director bought 1,800 shares at $3.77 ($6,786)
  4. 4 Exercise or conversion Chief Executive Officer acquired 20,000 shares (option exercise)
  5. 4 Open-market buy Chief Financial Officer bought 148,960 shares at an average $3.32 ($494,032)
  6. 4 Open-market buy Chief Medical Officer bought 38,000 shares at $3.15 ($119,844)
  7. 4 Open-market buy Chief Medical Officer bought 1,935 shares at $3.10 ($5,999)
  8. 4 Open-market buy Chief Executive Officer bought 1,500 shares at $3.34 ($5,010)
  9. 4 Open-market buy Chief Medical Officer bought 2,570 shares at $3.52 ($9,046)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Chief Financial Officer bought 27,250 shares at $2.37 ($64,583)
  15. 4 Open-market buy Chief Executive Officer bought 2,125 shares at $2.40 ($5,100)
  16. 4 Open-market buy Chief Financial Officer bought 30,000 shares at $2.39 ($71,700)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 17 · 340 filings